Johnson & Johnson: Headache trials
The registry lists 12 Headache studies with Johnson & Johnson as lead sponsor. 0 are open to participants now and 0 have results posted.
Phase 2 1Phase 3 6Phase 4 3No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Study on Migraine and Headache in Epileptic PatientsCompletedNCT00642564
- Efficacy and Safety of Sinutab on Subjects in the Setting of a Common ColdCompletedNCT00378144Phase 4
- A Study Comparing the Effectiveness and Safety of ULTRACET® (Tramadol HCl/Acetaminophen) Versus Placebo for the Treatment of Acute Pain From a Migraine HeadacheCompletedNCT00297375Phase 4
- A Study of the Prevalence of Headache in Epileptic PatientsCompletedNCT00277368
- An Open-label Study to Evaluate Topiramate Therapy in Migraine Patients, and Its Effects on Subject Responsiveness to Migraine Treatment With TriptansCompletedNCT00261469Phase 2
- A Study of the Effectiveness and Safety of Topiramate for the Prevention of MigraineCompletedNCT00253175Phase 3
- A Study of the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prevention of MigraineCompletedNCT00236561Phase 3
- A Study of the Efficacy and Safety of Topiramate in the Prevention of MigraineCompletedNCT00236509Phase 3
- A Study of the Efficacy and Safety of Topiramate in the Prevention of MigraineCompletedNCT00231595Phase 3
- Evaluation of the Effectiveness of Topiramate in Preventing the Transformation From Episodic Migraine to Chronic Daily Headache.CompletedNCT00212810Phase 4
- Comparing the Safety and Effectiveness of Topiramate With the Safety and Effectiveness of Amitriptyline in Preventing Migraine HeadachesCompletedNCT00210821Phase 3
- A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine Attacks in ChildrenCompletedNCT00210535Phase 3